Table 4.
References | Items | Total points (from a maximum of 15) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | ||
Ali et al. (2019) | 1 | – | – | 1 | – | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 10 |
Maio Alves et al. (2010) | 1 | – | 1 | 1 | – | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 11 |
Brito et al. (2014) | 1 | 1 | 1 | 1 | – | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 12 |
Cavaco et al. (2014) | 1 | 1 | 1 | 1 | – | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 12 |
Chatzinikolaou et al. (2018) | 1 | 1 | 1 | 1 | – | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 13 |
Faude et al. (2013) | 1 | 1 | 1 | – | – | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 12 |
García-Pinillos et al. (2014) | 1 | 1 | 1 | 1 | – | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 12 |
Hammami et al. (2017a) | 1 | 1 | 1 | – | – | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 11 |
Hammami et al. (2017b) | 1 | 1 | 1 | 1 | – | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 11 |
Hammami et al. (2019) | 1 | 1 | 1 | 1 | – | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 12 |
Note for items 1 through 12: (1) eligibility criteria specified (1 point); (2) randomization defined (1 point); (3) allocation concealment (1 point); (4) groups similar at baseline (1 point); (5) assessor blinding in study reporting (1 point); (6) outcome measures assessed in 85% of patients (3 points); (7) intention-to-treat analysis (1 point); (8) between-group statistical comparisons reported (2 points); (9) point measures and measures of variability for all reported outcome measures (1 point); (10) activity monitoring in the controlled group (1 point); (11) relative exercise intensity remained constant (1 point); (12) exercise volume and energy expenditure (1 point).